NHS National Framework for Aripiprazole prolonged release injection
NHS England · NHS and health
In brief
NHS England awarded medical supplies work to Sun Pharma UK Limited, Otsuka Pharmaceuticals UK Limited and Perennial Pharma Ltd on 14 August 2026.
It is a framework worth up to £24,467,000 excluding VAT: the most the buyer expects to spend across all suppliers, not one contract.
The contract runs for 2 years, up to 4 years with extensions, starting 1 February 2027.
The buyer says it is suitable for small and medium-sized businesses.
Built from the notice's own fields. Always check the official notice before you bid.
What the notice says
Who won
| Winner | Value | Dates |
|---|---|---|
| Sun Pharma UK Limited Otsuka Pharmaceuticals UK Limited (SME) Perennial Pharma Ltd 4 bids received | £32,140,000 | Awarded 29 July 2026 1 February 2027 to 31 January 2029 |
Values as the award notice gives them, excluding VAT where stated.
Timeline
- Pipeline notice · UK1, notice 022493-2026
- Preliminary market engagement notice · UK2, notice 030759-2026
- Tender notice · UK4, notice 049710-2026
- Contract award notice · UK6, notice 071653-2026
- Contract details notice · UK7, notice 081037-2026
Last time this was bought
NHS National Framework for Ferric Carboxymaltose injection
- Awarded
- 28 October 2026
- Value
- £29,759,000
- Bids
- 4
Matched on NHS England, the type of work and the title; it may be a related contract rather than the same one. Check the notice to be sure.
About the buyer
Procurements
1117Awards
471Suppliers it has used most for medical supplies
- Accord-UK Ltd11 contracts
- Teva UK Limited10 contracts
- Zentiva Pharma UK Ltd9 contracts
- Milpharm Limited8 contracts
- Pfizer Limited8 contracts
Similar open tenders
All open medical supplies tenders- £173kframework ceiling
- £173kframework ceiling
- £6.86mframework ceiling
From notice 022493-2026 on Find a Tender, first published 12 March 2026, last updated 25 August 2026. We last checked for changes on 28 September 2026.